+1-786-628-7980
Sign Up/Sign In 
Lotus Bio-Technology Development Corp. is excited to announce today that the company has begun the process of changing its name from Lotus Bio-Technology Development Corp. to Boomerang Corporation.
Regarding the name change, CEO Hoyt Christopher said, “This new name more closely reflects the approachable, personalized nature of our current and future business model which aims to empower users by making healthcare easily accessible, customizable, and controllable.”
Boomerang employs a similar business model to EverlyWell (currently valued at $2.9 Billion) and Hims & Hers, Inc. (currently valued at $1.2 Billion). Boomerang delivers test kits directly to users that include self-collection sample devices. The user then ships their sample back to one of Boomerang’s labs via a return-label for testing and receives their results digitally as well as a custom wellness plan based on the results. Boomerang currently offers testing supporting Men’s Health, Women’s Health, Sexual Health and COVID-19.
About Boomerang:
Boomerang saw an opportunity to reinvent healthcare by moving diagnostic tests into the comfort of home and providing users with an empowered path forward based on their results. Through state of the art at-home diagnostic testing, customizable wellness plans, and strategic partnerships, Boomerang is uniquely positioned to become a leader within the fast-growing billion-dollar digital health market.
More information about the company can be found at: boomerangkit.com
Contact:
David Ottestad, Creative Director
Email: ir@boomerandgkit.com
